Article
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy
2024-06-03
Abstract excerpt
<h4>Background</h4> Prostate cancer is a heterogenous disease, but once it becomes metastatic it eventually becomes treatment resistant. One mechanism of resistance to AR-targeting therapy is lineage plasticity, where the tumor undergoes a transformation to an AR-indifferent phenotype, most studied in the context of neuroendocrine prostate cancer (NEPC). However, activation of additional de- or trans-differentiat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ec8339a0-6061-599b-b274-ded093c1ca66
- DOI
- 10.1101/2024.06.02.595931
